While it is possible that aging (Feng et al. 2007) and the acquisition of other alterations (such as defects in the pathways necessary to activate p53) weaken the p53 response in tumors that retain WT p53, it seems likely that complete loss of WT p53 function is not necessary for tumor development, so limiting a requirement for any DN effect. This evidence concerns the gene TP53 and neoplasm.